Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy
Author:
Affiliation:
1. School of Life Science and Technology, China Pharmaceutical University, Nanjing, China;
2. Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China;
3. First Affiliated Hospital, Nanjing Medical University, Nanjing, China
Funder
This study was funded by National Natural Science Foundation of China
National High Technology Research and Development Program of China
Top-notch Academic Programs Project of Jiangsu Higher Education Institutions
The science and technology innovation team of “Jiangsu Province Blue Project”
Jiangsu province science and technology innovation team
Excellent Youth Foundation of Jiangsu Scientific Committee and Priority Academic Program Development of Jiangsu Higher Education Institutions
Publisher
Informa UK Limited
Subject
Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1434185
Reference40 articles.
1. Global cancer statistics
2. Drug Delivery Systems: Entering the Mainstream
3. Micellar Nanocarriers: Pharmaceutical Perspectives
4. The benefits and challenges associated with the use of drug delivery systems in cancer therapy
5. Poly(hydroxyethyl methacrylate) based magnetic nanoparticles for lysozyme purification from chicken egg white
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics;MedComm;2024-07-28
2. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle;Medicinal Research Reviews;2024-02
3. Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review;Frontiers in Bioengineering and Biotechnology;2023-09-12
4. The effects of mesenchymal stem cells on the chemotherapy of colorectal cancer;Biomedicine & Pharmacotherapy;2023-04
5. Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors;Progress in Biophysics and Molecular Biology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3